Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Robinhood’s November Metrics Signal a Pause in Trading Momentum

Andreas Sommer by Andreas Sommer
December 11, 2025
in Analysis, Crypto Stocks, Earnings, Trading & Momentum
0
Robinhood Stock
0
SHARES
24
VIEWS
Share on FacebookShare on Twitter

Robinhood Markets released its key performance indicators for November on December 10, painting a nuanced picture for the trading platform. Following an extraordinary rally of more than 260% in its share price since the start of the year, the latest data reveals a notable cooling in user trading activity. However, this slowdown coincides with sustained strength in another critical area: net asset inflows. This divergence raises questions about whether the platform is experiencing a brief consolidation or the early stages of a broader shift.

Robust Capital Inflows Contrast with Trading Dip

A standout figure from the November report is the continued robust net asset flow onto the platform. Robinhood recorded $7.1 billion in net deposits for the month. Over the trailing twelve-month period, these cumulative net inflows reached $70.2 billion, representing a 36% year-over-year increase.

Assets Under Custody (AUC) stood at $325 billion as of the end of November. While this marks a 5% decrease from October’s level—likely attributable to broader market movements—it still constitutes a substantial 67% gain compared to November of the previous year. The number of funded accounts saw a marginal decline, dipping by approximately 130,000 to 26.9 million, yet remains 2.1 million higher year-over-year.

Trading Volumes Retreat Across Key Segments

The most pronounced shift in November was a broad-based decline in trading volumes across Robinhood’s core offerings. Equity trading volume fell 37% month-over-month to $201.5 billion. Options trading activity also decreased, with 193.2 million contracts traded, down 28% from October. Even cryptocurrency volume, a recent growth driver, retreated by 12% to $28.6 billion.

Despite the monthly drop, the year-over-year comparison remains favorable. Equity trading volume for November was 37% higher than in the same month last year. Furthermore, margin balances surged by 147% to $16.8 billion compared to November 2024.

Should investors sell immediately? Or is it worth buying Robinhood?

Expansion Plans and Analyst Reaction

Amidst this mixed operational data, Robinhood is advancing its international strategy. The company plans to enter the Indonesian market through the acquisition of local broker PT Buana Capital Sekuritas and crypto firm PT Pedagang Aset Kripto. This transaction, targeted for completion in the first half of 2026, aims to tap into a market with an estimated 36 million investors.

In response to the November metrics, Bank of America adjusted its valuation model. On December 10, the firm reduced its price target for Robinhood shares from $166 to $154. However, it maintained its Buy rating. The analysts cited the weaker trading volumes as a near-term headwind but reiterated a positive view based on the platform’s persistent capital gathering strength.

Event Contracts Emerge as a Bright Spot

One segment bucking the downward volume trend was Event Contracts, which include prediction markets. Trading in this category rose 20% from October to 3.0 billion contracts in November, establishing it as an increasingly relevant contributor to overall platform activity.

The November snapshot presents a tale of two trends: softening user engagement in trading juxtaposed with unwavering confidence in the platform for holding assets. Whether this reflects a temporary pause following a remarkable run or the beginning of a more sustained normalization will become clearer in the months ahead.

Ad

Robinhood Stock: Buy or Sell?! New Robinhood Analysis from February 7 delivers the answer:

The latest Robinhood figures speak for themselves: Urgent action needed for Robinhood investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Robinhood: Buy or sell? Read more here...

Tags: Robinhood
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Next Post
CureVac Stock

BioNTech Moves to Full Control as CureVac Tender Clears Major Hurdles

Nestle Stock

Nestlé Shares Navigate Cost Challenges and Market Scrutiny

Nio Stock

Nio Shares Face Persistent Market Skepticism Despite Strong Delivery Growth

Recommended

CRWD stock news

Tower Research Capital LLC TRC Demonstrates Unwavering Confidence in CrowdStrike Holdings as Cybersecurity Leader

2 years ago
Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

Beacon Announces Interim Chief Financial Officer

2 years ago

Alaska Airlines Boeing 737 Investigation Missing Bolts and Safety Measures

2 years ago

Impressive Financial Performance for Kiniksa Pharmaceuticals

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Trending

Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

by Rodolfo Hanigan
February 7, 2026
0

Universal Insurance Holdings has reaffirmed its commitment to shareholder returns, declaring its regular quarterly dividend despite a...

Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com